12/19
06:35 am
nuvl
Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/19
06:30 am
nuvl
Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/9
06:30 am
nuvl
Nuvalent Appoints Grant Bogle to Board of Directors
Low
Report
Nuvalent Appoints Grant Bogle to Board of Directors
11/26
06:52 am
nuvl
Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference
Low
Report
Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/12
05:31 pm
nuvl
Nuvalent, Inc. (NASDAQ: NUVL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $115.00 price target on the stock.
Low
Report
Nuvalent, Inc. (NASDAQ: NUVL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $115.00 price target on the stock.
11/12
06:30 am
nuvl
Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results
Low
Report
Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results
10/24
07:16 am
nuvl
Nuvalent, Inc. (NASDAQ: NUVL) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $100.00 price target on the stock.
Low
Report
Nuvalent, Inc. (NASDAQ: NUVL) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $100.00 price target on the stock.
10/4
03:12 pm
nuvl
Nuvalent, Inc. (NASDAQ: NUVL) had its price target raised by analysts at JPMorgan Chase & Co. from $100.00 to $125.00. They now have an "overweight" rating on the stock.
Low
Report
Nuvalent, Inc. (NASDAQ: NUVL) had its price target raised by analysts at JPMorgan Chase & Co. from $100.00 to $125.00. They now have an "overweight" rating on the stock.